259 related articles for article (PubMed ID: 15849917)
1. [In vitro susceptibility of vaginal isolates of Candida vs clotrimazole and nystatin].
Suárez VL; Fernández Andreu CM
Rev Cubana Med Trop; 2003; 55(3):138-45. PubMed ID: 15849917
[TBL] [Abstract][Full Text] [Related]
2. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
Khan F; Baqai R
J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
[TBL] [Abstract][Full Text] [Related]
3. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ
Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765
[TBL] [Abstract][Full Text] [Related]
4. [In vitro nystatin sensitivity of vaginal isolates of Candida spp].
Andreu CM; Medina YE; Gonzáles TC; Llanes DM
Rev Cubana Med Trop; 2001; 53(3):194-8. PubMed ID: 15846923
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of 6 antifungal agents on candida species isolated as causative agents from vaginal and other clinical specimens.
Ellabib MS; ElJariny IA
Saudi Med J; 2001 Oct; 22(10):860-3. PubMed ID: 11744942
[TBL] [Abstract][Full Text] [Related]
7. [Susceptibility to nystatin of oral Candida isolates and its correlation with the response to treatment].
Santa Anna LM; Díaz Suárez LA; Illnait Zaragozí MT; Perurena Lancha MR; Cantelar de Francisco N; Fernández Andreu CM; Martínez Machín G
Rev Cubana Med Trop; 2010; 62(3):237-44. PubMed ID: 23437555
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of the activity of the preparation cerbiden against Candida spp].
Hladun NP; Bondarenko AS; Nahorna SS; Smyrnova OV
Mikrobiol Z; 2002; 64(6):57-61. PubMed ID: 12664551
[TBL] [Abstract][Full Text] [Related]
9. [Antimycotic sensitivities of the clinically isolated candidas].
Akgün Y; Akşit F
Mikrobiyol Bul; 1981 Jul; 15(2):112-20. PubMed ID: 7052253
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of clotrimazole for Candida strains isolated from recent patient samples.
Schmidt A
Arzneimittelforschung; 1995 Dec; 45(12):1338-40. PubMed ID: 8595097
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
12. [Occurrence and the sensitivity to drugs of fungi other than Candida albicans isolated from the vagina].
Pawlik B; Liber Z; Jurkowska E
Med Dosw Mikrobiol; 1989; 41(1):60-6. PubMed ID: 2668661
[TBL] [Abstract][Full Text] [Related]
13. [The mode of action of imidazole antimycotics: implications for sensitivity testing (author's transl)].
Haller I
Mykosen; 1979 Dec; 22(12):423-30. PubMed ID: 396473
[No Abstract] [Full Text] [Related]
14. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activity of coronarin D against Candida albicans.
Kaomongkolgit R; Jamdee K; Wongnoi S; Chimnoi N; Techasakul S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):61-6. PubMed ID: 22727093
[TBL] [Abstract][Full Text] [Related]
16. Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum.
Tzatzarakis MN; Tsatsakis AM; Charvalos E; Vakalounakis D
J Environ Sci Health B; 2001 May; 36(3):331-40. PubMed ID: 11411855
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
Fleck R; Dietz A; Hof H
J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and in vitro activity of antimycotics against candidal vaginal/skin/nail infections in Singapore.
Kwok YK; Tay YK; Goh CL; Kamarudin A; Koh MT; Seow CS
Int J Dermatol; 1998 Feb; 37(2):145-9. PubMed ID: 9542677
[TBL] [Abstract][Full Text] [Related]
19. [Torulopsis glabrata. Morphologic characteristics, biotyping and sensitivity to isolates of antifungal agents in vitro].
Pospisil J
Cesk Epidemiol Mikrobiol Imunol; 1991 Jan; 40(1):43-8. PubMed ID: 1826472
[TBL] [Abstract][Full Text] [Related]
20. Reduced Antifungal Susceptibility of Vulvovaginal Candida Species at Normal Vaginal pH Levels: Clinical Implications.
Spitzer M; Wiederhold NP
J Low Genit Tract Dis; 2018 Apr; 22(2):152-158. PubMed ID: 29474241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
